glp 1 skin care Patient Buzz: After GLP-1 Weight Loss | The Expert Weighs In The Untold Truth About GLP-1

Promising clinical trial data suggests big opportunity with Eli Lilly's retatrutide GLP-1 candidate.

By supporting microbial balance in the digestive tract, it helps maintain normal digestive and metabolic function.*

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

The potential biological mechanisms underlying their influence on cancer risk are complex, involving metabolic regulation, direct antitumor effects, immune modulation, and epigenetic changes

Get insights on navigating GLP-1 antagonist shortages and compounds as we navigate demand and supply challenges.